O54 Randomised, double-blind, placebo-controlled study investigating enterosgel® treatment of irrita...
O54 Randomised, double-blind, placebo-controlled study investigating enterosgel® treatment of irritable bowel syndrome with diarrhoea (RELIEVE IBS-D)
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Subjects
More information
Scope and Contents
Contents
IntroductionPatients with irritable bowel syndrome with diarrhoea (IBS-D) experience abdominal pain and diarrhoea, with few treatment options. The intestinal adsorbent Enterosgel binds harmful molecules in the gut and can reduce diarrhoea (Howell CA, et al. BMJ Open Gastroenterol. 2019;6(1):e000287).MethodsThis was a randomised multi-centre double-...
Alternative Titles
Full title
O54 Randomised, double-blind, placebo-controlled study investigating enterosgel® treatment of irritable bowel syndrome with diarrhoea (RELIEVE IBS-D)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2711592678
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711592678
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2022-BSG.54
